Profil bibliographique

Richard J. Jones

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

495Publications signalées

25117Citations signalées

1Affiliations récentes

Institutions déclarées

Sidney Kimmel Comprehensive Cancer Center

Domaines associés

Hematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsLymphoma Diagnosis and Treatment

Publications récentes

2026 articleOpenAlex

Donor Related Logistical Challenges in Hematopoietic Transplant: A Comparative Analysis of Related and Unrelated Donors

Frederick Ian LeMaistre, Kathryn Yarkony, Alexander J. Ambinder, Heather J. Symons et autres

0 citationsTransplantation and Cellular Therapy

Accès ouvert 2026 preprintOpenAlex

Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study

Jakob Wirbel, Wael Saber, Michael J. Martens, Jonathan U. Peled et autres

1 citationbioRxiv (Cold Spring Harbor Laboratory)

2025 articleOpenAlex

Personalized Desensitization for Donor-Specific Anti-HLA Antibodies in Allogeneic Blood or Marrow Transplantation

Christian B. Gocke, Marianna Zahurak, Ilias Sinanidis, Suraya A. Berger et autres

0 citationsTransplantation and Cellular Therapy

2025 articleOpenAlex

Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide

Amy E. DeZern, Marianna Zahurak, Tyler Cavin, Helen Byrnes et autres

4 citationsTransplantation and Cellular Therapy

Accès ouvert 2025 conference-abstractOpenAlex

DNMT3A, NPM1, and FLT3-ITD triple-mutated AML has a favorable prognosis in the era of FLT3 inhibitors

Shirley Mo, Alexander J. Ambinder, Amy E. DeZern, B. Douglas Smith et autres

2 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib

Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard J. Jones et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution. Results from the BMT CTN 1801 study.

Kayleigh Ingersoll Omdahl, Steven J. Siegel, Jiayi Dong, Susan DeWolf et autres

0 citationsBlood

2025 conference-abstractOpenAlex

Azacitidine (AZA) and donor lymphocyte infusion (DLI) is a viable salvage approach for chimerism-only relapse following allogeneic blood or marrow transplantation (BMT)

Isabela Stemple, Alexander J. Ambinder, Kathryn Yarkony, Richard J. Jones et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Post-allogeneic hematopoietic cell transplantation outcomes are similar after hypomethylating agent/venetoclax and intensive, cytarabine-based remission induction for Acute Myeloid Leukemia when using standardized, contemporary transplant techniques

John Preston Claiborne, Venkata Preetam Sandeep Kaduluri, Hua-Ling Tsai, Ivana Gojo et autres

0 citationsBlood

2025 conference-abstractOpenAlex

Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study

Steven J. Siegel, Susan DeWolf, Joseph Schmalz, Nicholas Winn et autres

0 citationsBlood

Accès ouvert 2025 preprintOpenAlex

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML

Theodoros Karantanos, Nour Sabiha Naji, Taha Ahmedna, J. David Peske et autres

0 citationsResearch Square

Accès ouvert 2025 articleOpenAlex

C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53

Nour Sabiha Naji, Sergiu Paşca, Theodora Chatzilygeroudi, Pablo Toledano-Sanz et autres

2 citationsHaematologica

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.